Cargando…
Oscillatory ERK Signaling and Morphology Determine Heterogeneity of Breast Cancer Cell Chemotaxis via MEK-ERK and p38-MAPK Signaling Pathways
Chemotaxis, regulated by oscillatory signals, drives critical processes in cancer metastasis. Crucial chemoattractant molecules in breast cancer, CXCL12 and EGF, drive the activation of ERK and Akt. Regulated by feedback and crosstalk mechanisms, oscillatory signals in ERK and Akt control resultant...
Autores principales: | Ho, Kenneth K. Y., Srivastava, Siddhartha, Kinnunen, Patrick C., Garikipati, Krishna, Luker, Gary D., Luker, Kathryn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952091/ https://www.ncbi.nlm.nih.gov/pubmed/36829763 http://dx.doi.org/10.3390/bioengineering10020269 |
Ejemplares similares
-
Robustness of MEK-ERK Dynamics and Origins of Cell-to-Cell Variability in MAPK Signaling
por: Filippi, Sarah, et al.
Publicado: (2016) -
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways
por: Li, Genhong, et al.
Publicado: (2023) -
ERK3/MAPK6 controls IL-8 production and chemotaxis
por: Bogucka, Katarzyna, et al.
Publicado: (2020) -
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020) -
ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)